CPT® Code 90670

The pneumococcal conjugate vaccine, 13 valent (PCV13), is a crucial immunization designed to provide active and long-term immunity against pneumococcal diseases. Vaccines function by introducing altered versions of specific pathogens, such as viruses or bacteria, into the body. This exposure prompts the immune system to produce antibodies, which are proteins that help fight off infections. Once the immune system has been exposed to the vaccine, it retains a memory of how to produce these antibodies, enabling a quicker and more effective response if the individual encounters the actual pathogen in the future. Pneumococcal bacteria, specifically Streptococcus pneumoniae, can reside harmlessly in the nose and throat; however, they pose a significant risk when they invade other parts of the body, potentially leading to severe conditions such as pneumococcal pneumonia, bacteremia, and meningitis. Certain populations, including young children, the elderly, and individuals with compromised immune systems, are particularly vulnerable to these infections. The PCV13 vaccine is formulated using a purified component of the bacteria's cell wall, which is combined with a nontoxic variant of diphtheria known as CRM197, serving as a carrier to enhance the immune response. This specific vaccine covers 13 different serotypes of Streptococcus pneumoniae, which are responsible for a majority of pneumococcal disease cases. The vaccine is administered via an intramuscular injection, and it is important to note that there are other pneumococcal vaccines available, such as the 15 valent vaccine (PCV15), which offers broader coverage by including additional serotypes. The use of the PCV13 vaccine is essential in preventing serious pneumococcal infections and protecting at-risk populations.